Monitor the special meeting vote outcome on November 20—passage unlocks ~$11.6M in warrant proceeds but triggers massive dilution. The Offering Proposal's 10M-share authorization (8.6x current float) signals further capital needs. Watch for any subsequent registration statements or pricing of future offerings.
Price Chart
Executive Summary
bioAffinity Technologies is holding a special meeting on November 20, 2026, to seek stockholder approval for the issuance of up to 2,108,344 shares of common stock upon exercise of warrants from two private placements (August and October 2026), authorization for future non-public offerings of up to 10 million shares, and a reduction in authorized shares from 350 million to 200 million. The warrant exercises would unlock up to ~$11.6 million in gross proceeds critical for funding operations, but approval would cause significant dilution—nearly doubling the current 1,166,625 outstanding shares. The filing is a routine capital-raising proxy with no executive compensation, director elections, shareholder proposals, or related-party transactions disclosed.
Key Facts
- Special meeting on November 20, 2026, to vote on five proposals, all recommended FOR by the Board.
- Proposal 1: Approve issuance of up to 1,128,272 shares upon exercise of August 2026 Warrants (exercise price $4.9757/share, potential ~$5.6M gross proceeds).
- Proposal 2: Approve issuance of up to 980,072 shares upon exercise of October 2026 Common Warrants (exercise price $6.122/share, potential ~$6.0M gross proceeds).
- Proposal 3: Authorize future non-public offerings of up to 10,000,000 shares for up to $15M in cash, at up to 20% discount, through November 20, 2027.
- Proposal 4: Reduce authorized common stock from 350,000,000 to 200,000,000 shares.
- As of September 23, 2026 record date, there were 1,166,625 shares outstanding.
- Full exercise of both warrants would add 2,108,344 new shares, nearly doubling the current float.
- No executive compensation details, director elections, shareholder proposals, or related-party transactions are presented in this special meeting proxy.
Financial Impact
Up to ~$11.6 million in gross proceeds if all warrants are exercised for cash; potential dilution of ~181% of current outstanding shares if both warrants and the full 10M-share offering authorization are utilized.
Risk Factors
- Failure to approve warrant proposals could cut off ~$11.6M in potential funding, threatening operations.
- Approval of all proposals could result in extreme dilution—up to 12.1M new shares vs. 1.17M currently outstanding.
- The company has a $5M market cap and 0% analyst bullish consensus, indicating severe financial distress.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEF 14A Filing (Primary) | 0001493152-26-048245 |
| Document: 0001493152-26-048245-index-headers.html | 0001493152-26-048245 |
| Document: 0001493152-26-048245-index.html | 0001493152-26-048245 |
| Document: 0001493152-26-048245.txt | 0001493152-26-048245 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | DEF 14A | $2.83 | awaiting T+60 | — | $2.96 (+4.59%) |
Oct 15, 2026 12d ago | 8-K | $3.96 | awaiting T+60 | — | $2.96 (−25.25%) |
Oct 13, 2026 14d ago | 8-K | $3.63 | awaiting T+60 | — | $2.96 (−18.34%) |
Oct 9, 2026 18d ago | 8-K | $3.90 | awaiting T+60 | — | $2.96 (+24.10%) |
Oct 9, 2026 18d ago | 424B5 | $4.73 | awaiting T+60 | — | $2.96 (+37.35%) |
Oct 9, 2026 18d ago | 424B5 | $4.73 | awaiting T+60 | — | $2.96 (−37.35%) |
Oct 8, 2026 19d ago | 8-K | $5.64 | awaiting T+60 | — | $2.96 (−47.52%) |
Oct 6, 2026 21d ago | 8-K | $6.06 | awaiting T+60 | — | $2.96 (−51.16%) |
Sep 30, 2026 27d ago | 8-K | $6.56 | awaiting T+60 | — | $2.96 (−54.88%) |
Sep 22, 2026 5w ago | 8-K | $8.56 | awaiting T+60 | — | $2.96 (−65.40%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers